CTOs on the Move

OXiGENE

www.oxigene.com

 
OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.oxigene.com
  • 701 Gateway Blvd Suite 210
    South San Francisco, CA USA 94080
  • Phone: 650.635.7000

Executives

Name Title Contact Details

Similar Companies

Venus Laboratories Inc

Venus Laboratories Inc is a Wood Dale, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pleomorphic Product Sales

Pleomorphic Product Sales is a Glendale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medron International

Medron International is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CoreMap

CoreMap`s goal is to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.

Integrated Medical Systems International

Integrated Medical Systems International is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.